Aronex Pharma (ARNX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stemwriter who wrote (127)	8/4/1998 5:38:00 PM
From: Caveat Emptor	Read Replies (1) of 320

What about TRETINOIN? Aronex has some type of collaboration with Genzyme Corporation to develop TRETINOIN - Treatment of Karposi's Sarcoma and Leukemia. I am confused about this drug. I don't see it mentioned in the product pipeline, and I don't know what the deal is with Genzyme. Also, if you research the drug further, a drug called TRETINOIN / RENOVA apparently is approved (in some form) for treatment of skin wrinkles. The distribution agreement for the skin drug is with J+J Ortho Pharmaceuticals. My points of reference are: oakinv.com pharminfo.com aegis.com Questions: What stake does ARONEX have in Tretinoin? (in any form) What are the terms of the collaboration agreement with Genzyme? Is the skin drug and the Sarcoma/Leukemia drug the same? Any feedback/info would be helpful. Thanx CAVEAT EMPTOR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next